Janssen

Danish biotech Genmab hit by ending of trial using key cancer drug
Danish biotech Genmab hit by ending of trial using key cancer drug
Reuters
Genmab
JNJ
Janssen
Darzalex
Flag link:
Janssen drops the BACE as Alzheimer’s candidate joins fail list
Janssen drops the BACE as Alzheimer’s candidate joins fail list
Fierce Biotech
JNJ
Janssen
BACE inhibitors
atabacestat
Alzheimer's disease
Flag link:
Janssen obtains FDA approval for Darzalex (multiple myeloma)
Janssen obtains FDA approval for Darzalex (multiple myeloma)
GoinPharma
Janssen
JNJ
Darzalex
Takeda
Velcade
Multiple Myeloma
FDA
Flag link:
J&J’s Janssen touts Ph3 data for antidepressant nasal spray
J&J’s Janssen touts Ph3 data for antidepressant nasal spray
Drug Delivery Business News
JNJ
Janssen
esketamine
depression
Flag link:
J&J’s Janssen acquires cancer-killing virus tech
J&J’s Janssen acquires cancer-killing virus tech
Drug Delivery Business News
JNJ
Janssen
BeneVir
oncolytic viruses
Flag link:
Moving Beyond Obesity, Vivus Strikes $135M Deal for Digestive Drug
Moving Beyond Obesity, Vivus Strikes $135M Deal for Digestive Drug
Xconomy
Vivus
Qsymia
Pancreaze
Janssen
Flag link:
Bristol-Myers Squibb and Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy
Bristol-Myers Squibb and Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy
CP Wire
Bristol-Myers Squibb
Janssen
Factor XIa
stroke
Flag link:
Bristol-Myers Squibb and Janssen to Develop and Commercialize Next-Generation Cardiovascular Therapy
Bristol-Myers Squibb
Janssen
Factor XIa
stroke
Flag link:
Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices
Payer Power: Why Eli Lilly, Janssen, and Merck Deeply Discount Their Drug Prices
Drug Channels
Eli Lilly
Janssen
Merck
drug pricing
drug discounts
Flag link:
Janssen’s New Transparency Report: A Peek Behind the Drug Pricing Curtain Raises Troubling Questions About Rebates
Janssen’s New Transparency Report: A Peek Behind the Drug Pricing Curtain Raises Troubling Questions About Rebates
Drug Channels
Janssen
transparency
drug pricing
rebates
drug discounts
Flag link:
A Possible Financial Boost Awaits Thousands Of Out-Of-State Plaintiffs In Risperdal suit
A Possible Financial Boost Awaits Thousands Of Out-Of-State Plaintiffs In Risperdal suit
Forbes
Risperdal
Philadelphia
Janssen
JNJ
Flag link:
Beat you to it, Purdue. Other opioid makers already ditched promotions
Beat you to it, Purdue. Other opioid makers already ditched promotions
Fierce Pharma
Purdue
opioids
opioid crisis
drug marketing
Teva Pharmaceutical
Janssen
Allergan
Endo International
Flag link:
As CAR-Ts go from candidates to brands, what's the marketing strategy?
As CAR-Ts go from candidates to brands, what's the marketing strategy?
Medical Marketing and Media
CAR-T
drug marketing
JCAR017
Juno Therapeutics
Celgene
bb2121
Bluebird Bio
apalutamide
Janssen
Flag link:
Janssen Oncology rolls out Cancer.com, a website that's been years in the making
Janssen Oncology rolls out Cancer.com, a website that's been years in the making
Fierce Pharma
Janssen
cancer
JNJ
digital marketing
Flag link:
ASH: Johnson & Johnson scores big Darzalex win in first-line myeloma, slashing risks in half
ASH: Johnson & Johnson scores big Darzalex win in first-line myeloma, slashing risks in half
Fierce Pharma
ASH17
JNJ
Darzalex
Multiple Myeloma
Janssen
Flag link:
Fresh off its Juluca approval, GlaxoSmithKline beefs up trials of long-acting HIV duo
Fresh off its Juluca approval, GlaxoSmithKline beefs up trials of long-acting HIV duo
Fierce Pharma
GSK
cabotegravir
HIV
Endurant
ViiV
JNJ
Janssen
Flag link:
Janssen drops U.S. lawsuit against Samsung Bioepis' Remicade copy
Janssen drops U.S. lawsuit against Samsung Bioepis' Remicade copy
Yahoo/Reuters
Janssen
Samsung Bioepis
Remicade
biosimilars
rheumatoid arthritis
Flag link:
Don't give up on tough-to-treat depression, Janssen R&D says in new video push
Don't give up on tough-to-treat depression, Janssen R&D says in new video push
Fierce Pharma
clinical depression
Janssen
R&D
JNJ
Flag link:
Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar
Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar
First Word Pharma
Pfizer
JNJ
Janssen
Remicade
biosimilars
Inflectra
Flag link:
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars
Drug Channels
drug pricing
reimbursement
Remicade
biosimilars
Janssen
Inflectra
Pfizer
Renflexis
Merck
Flag link:

Pages